Qube Research & Technologies (QRT)
TEVA icon

Qube Research & Technologies (QRT)’s Teva Pharmaceuticals TEVA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,500
Closed -$78K – 4122
2025
Q4 		$78K Sell
2,500
-2,500
-50% -$61.6K ﹤0.01% 3229
2025
Q3 		$101K Sell
5,000
-19,400
-80% -$341K ﹤0.01% 3064
2025
Q2 		$409K Buy
+24,400
New +$394K ﹤0.01% 2746

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TEVA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 59,306 shares — an estimated $1.98M sold.

Qube Research & Technologies (QRT) first reported a position in TEVA in Q2 2020 and held it in 13 quarters. The position peaked at $45.1M in Q1 2025. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 59,306 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.98M.
  • Qube Research & Technologies (QRT) first reported a position in Teva Pharmaceuticals in Q2 2020 and held it in 13 quarters.
  • Qube Research & Technologies (QRT)'s Teva Pharmaceuticals position peaked at $45.1M in Q1 2025.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.